Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|July 16, 2008
High expression of indoleamine 2,3-dioxygenase gene in prostate cancerChantal Feder-Mengus, Stephen Wyler, Tvrtko Hudolin, et al.
Stroke|November 22, 2008
Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcriptionAlessandra Valerio, Marta Dossena, Paola Bertolotti, et al.
British Journal of Pharmacology|March 21, 2017
Dexpramipexole improves bioenergetics and outcome in experimental strokeMirko Muzzi, Elisabetta Gerace, Daniela Buonvicino, et al.
European Journal of Neurology|September 17, 2024
Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort studyLuigi Francesco Iannone, Marina Romozzi, Antonio Russo, et al.
The Journal of Headache and Pain|January 6, 2025
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study)Luigi Francesco Iannone, Gloria Vaghi, Gabriele Sebastianelli, et al.
British Journal of Pharmacology|February 19, 2017
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseasesNathan A Berger, Valerie C Besson, A Hamid Boulares, et al.
Cephalalgia : an International Journal of Headache|November 26, 2024
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional studyGiorgio Dalla Volta, Antonio Russo, Marcello Silvestro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2023
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)Agnese Onofri, Luigi Francesco Iannone, Antonio Granato, et al.
CNS Drugs|November 24, 2023
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort StudyValeria Caponnetto, Antonio Russo, Marcello Silvestro, et al.
Cephalalgia : an International Journal of Headache|February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
Pageof 14